Contract

Medicines Discovery Catapult - Electronic Laboratory Notebook (ELN) and Laboratory Information Management System (LIMS)

  • MEDICINES DISCOVERY CATAPULT LIMITED

F03: Contract award notice

Notice identifier: 2024/S 000-006941

Procurement identifier (OCID): ocds-h6vhtk-03d6a9

Published 5 March 2024, 9:04am



Section one: Contracting authority

one.1) Name and addresses

MEDICINES DISCOVERY CATAPULT LIMITED

Block 35g,Mereside, Alderley Park

MACCLESFIELD

SK104ZF

Contact

Phil Sinha Jones

Email

phil.sinhajones@md.catapult.org.uk

Telephone

+44 7546076885

Country

United Kingdom

Region code

UKD62 - Cheshire East

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://md.catapult.org.uk

one.4) Type of the contracting authority

Other type

Drug Discovery / Health

one.5) Main activity

Other activity

Drug Discovery / Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Medicines Discovery Catapult - Electronic Laboratory Notebook (ELN) and Laboratory Information Management System (LIMS)

two.1.2) Main CPV code

  • 48000000 - Software package and information systems

two.1.3) Type of contract

Supplies

two.1.4) Short description

Research data is the primary deliverable of MDC and it is essential to have an evident and secure way of its documentation. The data will be used to advance internal capability-build and external fee-for-service research projects from a diverse set of scientific technologies, including Mass Spectrometry, Imaging, In-vivo Imaging, Complex Cells, Biomarker and Target Engagement & Validation studies. Consistent with MDC's vision of collaborative working, the platform must enable seamless data sharing for internal and external projects with scientists and institutions.

The software's main task is to document research data and to provide evidence of Good Laboratory Practice as well as improving lab productivity and efficiency, by keeping track of data associated with samples, experiments, laboratory workflows, and instruments. MDC does not currently have a commercial ELN as the previous ELN contract ended in July 2021.

The current means of tracking samples and laboratory consumables is a combination of paper-based documentation and Microsoft spreadsheets. This is no longer fit for purpose as the business expands and diversifies to include work with clinical samples. As such, MDC now requires a robust LIMS with full traceability to ensure that quality is maintained and to readily demonstrate the integrity of work involving clinical samples.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

Research data is the primary deliverable of MDC and it is essential to have an evident and secure way of its documentation. The data will be used to advance internal capability-build and external fee-for-service research projects from a diverse set of scientific technologies, including Mass Spectrometry, Imaging, In-vivo Imaging, Complex Cells, Biomarker and Target Engagement & Validation studies. Consistent with MDC's vision of collaborative working, the platform must enable seamless data sharing for internal and external projects with scientists and institutions.

The software's main task is to document research data and to provide evidence of Good Laboratory Practice as well as improving lab productivity and efficiency, by keeping track of data associated with samples, experiments, laboratory workflows, and instruments. MDC does not currently have a commercial ELN as the previous ELN contract ended in July 2021.

The current means of tracking samples and laboratory consumables is a combination of paper-based documentation and Microsoft spreadsheets. This is no longer fit for purpose as the business expands and diversifies to include work with clinical samples. As such, MDC now requires a robust LIMS with full traceability to ensure that quality is maintained and to readily demonstrate the integrity of work involving clinical samples.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2023/S 000-017058

four.2.9) Information about termination of call for competition in the form of a prior information notice

The contracting authority will not award any further contracts based on the above prior information notice


Section five. Award of contract

A contract/lot is awarded: No

five.1) Information on non-award

The contract/lot is not awarded

Other reasons (discontinuation of procedure)


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Medicines Discovery Catapult

Alderley Park

Macclesfield

SK10 4ZF

Email

phil.sinhajones@md.catapult.org.uk

Telephone

+44 1625725225

Country

United Kingdom